Abstract
In January 2008, a 67-year-old woman was admitted to our hospital because of hepatitis C virus-related cirrhosis and hepatocellular carcinoma (HCC). In February 2010, she had tarry stools and anemia resulting from gastric antral vascular ectasia (GAVE). Argon plasma coagulation (APC) treatment for GAVE was performed at that time. She revisited our hospital in July 2010 because of tarry stools and anemia caused by GAVE recurrence, which required 5 APC sessions and blood transfusion to control the bleeding. In October 2010, she arrived at our hospital by ambulance because of hemorrhagic shock resulting from GAVE recurrence. Despite performing 5 APC sessions and multiple blood transfusions, the tarry stools and anemia persisted during the hospitalization period. In December 2010 and January 2011, second-stage selective transcatheter arterial embolization (TAE) of the right gastric and right gastroepiploic arteries using microcoils was performed for the treatment of the refractory GAVE. Upper gastrointestinal endoscopy performed after TAE revealed the disappearance of mucosal diffuse spotty redness. In addition, no complications such as gastric ulcer and necrosis were observed. Selective TAE, effectively resolved the GAVE and anemia, and no recurrence has been observed during the last 24 months. Therefore, TAE may be a safe and radical treatment for refractory GAVE.
Similar content being viewed by others
References
Payen J, Cales P, Voigt J, et al. Severe portal hypertensive gastropathy and antral vascular ectasia are distinct entities in patients with cirrhosis. Gastroenterology. 1995;108:138–44.
Dulai GS, Jensen DM, Kovacs TO, et al. Endoscopic treatment outcomes in watermelon stomach patients with and without portal hypertension. Endoscopy. 2004;36:68–72.
Terawaki H, Kobayashi S, Kato J, et al. A case report of hemodialysis patient who presented recurrent bleeding from gastric antral vascular ectasia (GAVE) associated with liver cirrhosis: the effectiveness of trans-arterial embolization to bilateral gastric arteries. J Jpn Soc Dial Ther. 2008;41:803–8.
Rider JA, Klotz AP, Kirsner JB. Gastritis with veno-capillary ectasia as a source of massive gastric hemorrhage. Gastroenterology. 1953;24:118–23.
Jabbari M, Cherry R, Lough JO, et al. Gastric antral vascular ectasia: the watermelon stomach. Gastroenterology. 1984;87:1165–70.
Lee FL, Costello F, Flanagan N, et al. Diffuse antral vascular ectasia. Gastrointest Endosc. 1984;30:87–90.
Sebastian S, O’Morain CA, Buckley MJ. Review article: current therapeutic options for gastric antral vascular ectasia. Aliment Pharmacol Ther. 2003;18:157–65.
Gostout CJ, Viggiano TR, Ahlquist DA, et al. The clinical and endoscopic spectrum of the watermelon stomach. J Clin Gastroenterol. 1992;15:256–63.
Sato T, Yamazaki K, Akaike J, et al. Endoscopic band ligation for refractory gastric antral vascular ectasia associated with liver cirrhosis. Clin J Gastroenterol. 2011;4:108–11.
Moss SF, Ghosh P, Thomas DM, et al. Gastric antral vascular ectasia: maintenance treatment with estrogen-progesterone. Gut. 1992;33:715–7.
McCormick PA, Ooi H, Crosbie O. Tranexamic acid for severe bleeding gastric antral vascular ectasia in cirrhosis. Gut. 1998;42:750–2.
Peterson A, Varga J. Cyclophosphamide: a novel treatment of gastric antral vascular ectasia associated with systemic sclerosis? Curr Rheumatol Rep. 2010;12:4–7.
Sargeant IR, Loizou LA, Rampton D, et al. Laser ablation of upper gastrointestinal vascular ectasias: long term results. Gut. 1993;34:470–5.
Fuccio L, Zagari RM, Serrani M, et al. Endoscopic argon plasma coagulation for the treatment of gastric antral vascular ectasia-related bleeding in patients with liver cirrhosis. Digestion. 2009;79:143–50.
Gross SA, Al-Haddad M, Gill KRS, et al. Endoscopic mucosal ablation for the treatment of gastric antral vascular ectasia with the HALO90 system: a pilot study. Gastrointest Endosc. 2008;67:324–7.
Lecleire S, Ben-Soussan E, Antonietti M, et al. Bleeding gastric vascular ectasia treated by argon plasma coagulation: a comparison between patients with and without cirrhosis. Gastrointest Endosc. 2008;67:219–25.
Nakamura S, Mitsunaga A, Konishi H, et al. Long-term follow up of gastric vascular ectasia treated by argon plasma coagulation. Dig Endosc. 2006;18:128–33.
Je Y, Schutz FA, Choueiri TK. Risk of bleeding with vascular endothelial growth factor receptor tyrosine-kinase inhibitors sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials. Lancet Oncology. 2009;10:967–74.
Parente F, Petrillo M, Vago F, et al. The watermelon stomach: clinical, endoscopic, endosonographic, and therapeutic aspects in three cases. Endoscopy. 1995;27:203–6.
Robertson I, Tait N, Jackson J. Vascular ectasia of the gastric antrum: angiographic findings. Am J Roentgenol. 1996;166:87–9.
Ashiya E, Yagi N, Shiomi H, et al. A case report of gastric vascular ectasia patient successfully treated by trans-arterial embolization despite the inefficiency of argon plasma coagulation. Jpn J Gastroenterol. 2003;100:A304.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yoshida, H., Takahashi, H., Akoshima, H. et al. Successful treatment of refractory gastric antral vascular ectasia using transcatheter arterial embolization. Clin J Gastroenterol 6, 231–236 (2013). https://doi.org/10.1007/s12328-013-0385-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12328-013-0385-y